Unlike the IV and inhaled anesthetics in prevalent clinical use, ketamine is not really believed to act largely in the potentiation of gamma-aminobutyric acid (GABA) transmission. Early Focus on the mechanisms of ketamine uncovered that it decreased neuronal excitation by NMDA, the agonist for which the glutamatergic receptor sort is named (Anis et